BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34229244)

  • 1. Contribution of rapid lateral flow assays from capillary blood specimens to the diagnosis of COVID-19 in symptomatic healthcare workers: a pilot study in a university hospital, Paris, France.
    Charpentier C; Pellissier G; Ichou H; Ferré VM; Larfi I; Phung BC; Vallois D; LeGac S; Aubier M; Descamps D; Fidouh-Houhou N; Bouvet E
    Diagn Microbiol Infect Dis; 2021 Oct; 101(2):115430. PubMed ID: 34229244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of three point-of-care lateral flow immunoassays for detection of anti-SARS-CoV-2 antibodies: data from 100 healthcare workers in Brazil.
    Conte DD; Carvalho JMA; de Souza Luna LK; Faíco-Filho KS; Perosa AH; Bellei N
    Braz J Microbiol; 2021 Sep; 52(3):1161-1165. PubMed ID: 33871824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 Seroprevalence in Healthcare Workers of Kaunas Hospitals during the First Wave of the COVID-19 Pandemic.
    Pereckaitė L; Dambrauskienė A; Urbonienė D; Sadauskas S; Petrikonis K; Naudžiūnas A; Vitkauskienė A
    Medicina (Kaunas); 2021 Feb; 57(2):. PubMed ID: 33562085
    [No Abstract]   [Full Text] [Related]  

  • 4. SARS-CoV-2 lateral flow assays for possible use in national covid-19 seroprevalence surveys (React 2): diagnostic accuracy study.
    Moshe M; Daunt A; Flower B; Simmons B; Brown JC; Frise R; Penn R; Kugathasan R; Petersen C; Stockmann H; Ashby D; Riley S; Atchison C; Taylor GP; Satkunarajah S; Naar L; Klaber R; Badhan A; Rosadas C; Marchesin F; Fernandez N; Sureda-Vives M; Cheeseman H; O'Hara J; Shattock R; Fontana G; Pallett SJC; Rayment M; Jones R; Moore LSP; Ashrafian H; Cherapanov P; Tedder R; McClure M; Ward H; Darzi A; Elliott P; Cooke GS; Barclay WS;
    BMJ; 2021 Mar; 372():n423. PubMed ID: 33653694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The seroprevalence of SARS-CoV-2 in a rural southwest community.
    Santarelli A; Lalitsasivimol D; Bartholomew N; Reid S; Reid J; Lyon C; Wells J; Ashurst J
    J Osteopath Med; 2021 Feb; 121(2):199-210. PubMed ID: 33567087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Serological SARS-CoV-2 Lateral Flow Assays for Rapid Point-of-Care Testing.
    Conklin SE; Martin K; Manabe YC; Schmidt HA; Miller J; Keruly M; Klock E; Kirby CS; Baker OR; Fernandez RE; Eby YJ; Hardick J; Shaw-Saliba K; Rothman RE; Caturegli PP; Redd AD; Tobian AAR; Bloch EM; Larman HB; Quinn TC; Clarke W; Laeyendecker O
    J Clin Microbiol; 2021 Jan; 59(2):. PubMed ID: 33208477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical diagnostic performance evaluation of five immunoassays for antibodies to SARS-CoV-2 diagnosis in a real-life routine care setting.
    Akyala AI; Awayimbo JR; Ogo AC; Chima NJ; Billyrose OMA; Engom AOG
    Pan Afr Med J; 2021; 39():3. PubMed ID: 34178231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating 10 Commercially Available SARS-CoV-2 Rapid Serological Tests by Use of the STARD (Standards for Reporting of Diagnostic Accuracy Studies) Method.
    Dortet L; Ronat JB; Vauloup-Fellous C; Langendorf C; Mendels DA; Emeraud C; Oueslati S; Girlich D; Chauvin A; Afdjei A; Bernabeu S; Le Pape S; Kallala R; Rochard A; Verstuyft C; Fortineau N; Roque-Afonso AM; Naas T
    J Clin Microbiol; 2021 Jan; 59(2):. PubMed ID: 33239381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of four high-throughput, automated immunoassays for the detection of SARS-CoV-2 antibodies.
    Oakey J; Haslam S; Brown A; Eglin J; Houghton B; Singleton D
    Ann Clin Biochem; 2021 Sep; 58(5):487-495. PubMed ID: 33892600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The reliability of SARS-CoV-2 IgG antibody testing - a pilot study in asymptomatic health care workers in a Croatian university hospital.
    Lapić I; Rogić D; Šegulja D; Kralik Oguić S; Knežević J
    Croat Med J; 2020 Dec; 61(6):485-490. PubMed ID: 33410294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Anti-SARS-CoV-2 Specific Antibodies in Health-Care Workers Compared to General Population during an Early Phase of the Pandemic, Tehran-Iran.
    Mortezagholi S; Rostamzadeh D; Alinejad M; Younesi V; Tabarsi P; Shabani M
    Iran J Immunol; 2021 Mar; 18(1):82-92. PubMed ID: 33787517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A lateral flow immunoassay test performance in SARS-CoV-2 seroprevalence surveys: a validation study among healthcare workers.
    Garlantézec R; Heslan C; Tadie E; Tattevin P; Thibault V; Paris C
    Emerg Microbes Infect; 2020 Dec; 9(1):2547-2549. PubMed ID: 33206004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 IgG/IgM Rapid Test as a Diagnostic Tool in Hospitalized Patients and Healthcare Workers, at a large Teaching Hospital in northern Italy, during the 2020 COVID-19 Pandemic.
    Canetti D; Dell'Acqua R; Riccardi N; Della Torre L; Bigoloni A; Muccini C; Bruzzesi E; Ranzenigo M; Chiurlo M; Racca S; Galli C; Castagna A; Tambussi G; Lazzarin A
    New Microbiol; 2020 Oct; 43(4):161-165. PubMed ID: 33135083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 infections among healthcare workers at Helsinki University Hospital, Finland, spring 2020: Serosurvey, symptoms and risk factors.
    Kantele A; Lääveri T; Kareinen L; Pakkanen SH; Blomgren K; Mero S; Patjas A; Virtanen J; Uusitalo R; Lappalainen M; Järvinen A; Kurkela S; Jääskeläinen AJ; Vapalahti O; Sironen T
    Travel Med Infect Dis; 2021; 39():101949. PubMed ID: 33321195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unexpected high frequency of unspecific reactivities by testing pre-epidemic blood specimens from Europe and Africa with SARS-CoV-2 IgG-IgM antibody rapid tests points to IgM as the Achilles heel.
    Mboumba Bouassa RS; Péré H; Tonen-Wolyec S; Longo JD; Moussa S; Mbopi-Keou FX; Mossoro-Kpinde CD; Grésenguet G; Veyer D; Bélec L
    J Med Virol; 2021 Apr; 93(4):2196-2203. PubMed ID: 33107601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analytical performances of five SARS-CoV-2 whole-blood finger-stick IgG-IgM combined antibody rapid tests.
    Péré H; Mboumba Bouassa RS; Tonen-Wolyec S; Podglajen I; Veyer D; Bélec L
    J Virol Methods; 2021 Apr; 290():114067. PubMed ID: 33476707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of SARS-CoV-2-specific antibodies via rapid diagnostic immunoassays in COVID-19 patients.
    Chansaenroj J; Yorsaeng R; Posuwan N; Puenpa J; Sudhinaraset N; Chirathaworn C; Poovorawan Y
    Virol J; 2021 Mar; 18(1):52. PubMed ID: 33750394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analytical performance of lateral flow immunoassay for SARS-CoV-2 exposure screening on venous and capillary blood samples.
    Black MA; Shen G; Feng X; Garcia Beltran WF; Feng Y; Vasudevaraja V; Allison D; Lin LH; Gindin T; Astudillo M; Yang D; Murali M; Iafrate AJ; Jour G; Cotzia P; Snuderl M
    J Immunol Methods; 2021 Feb; 489():112909. PubMed ID: 33166549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal assessment of SARS-CoV-2 IgG seroconversionamong front-line healthcare workers during the first wave of the Covid-19 pandemic at a tertiary-care hospital in Chile.
    Iruretagoyena M; Vial MR; Spencer-Sandino M; Gaete P; Peters A; Delgado I; Perez I; Calderon C; Porte L; Legarraga P; Anderson A; Aguilera X; Vial P; Weitzel T; Munita JM
    BMC Infect Dis; 2021 May; 21(1):478. PubMed ID: 34039287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Advances in the Evaluation of Serological Assays for the Diagnosis of SARS-CoV-2 Infection and COVID-19.
    Chiereghin A; Zagari RM; Galli S; Moroni A; Gabrielli L; Venturoli S; Bon I; Rossini G; Saracino IM; Pavoni M; Lafratta S; Deni A; Felici S; Borghi M; Guerra L; Raumer L; Lodi V; Viale P; Attard L; Lazzarotto T;
    Front Public Health; 2020; 8():620222. PubMed ID: 33681115
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.